GW&K Investment Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,078,728
Closed -$14.5M 315
2018
Q4
$14.5M Sell
1,078,728
-97,681
-8% -$1.65M 0.29% 150
2018
Q3
$22.8M Buy
1,176,409
+161,857
+16% +$3.45M 0.37% 125
2018
Q2
$25.9M Sell
1,014,552
-9,784
-1% -$228K 0.42% 99
2018
Q1
$20.6M Buy
1,024,336
+19,222
+2% +$448K 0.35% 128
2017
Q4
$20.2M Sell
1,005,114
-210,665
-17% -$4.14M 0.34% 125
2017
Q3
$25.2M Buy
1,215,779
+482,648
+66% +$8.16M 0.42% 108
2017
Q2
$10.8M Sell
733,131
-26,416
-3% -$440K 0.19% 171
2017
Q1
$12.1M Buy
759,547
+22,522
+3% +$325K 0.23% 157
2016
Q4
$9.29M Sell
737,025
-145,657
-17% -$2.71M 0.18% 169
2016
Q3
$24.7M Sell
882,682
-17,295
-2% -$580K 0.46% 94
2016
Q2
$31.5M Sell
899,977
-32,426
-3% -$1.02M 0.65% 61
2016
Q1
$25.5M Sell
932,403
-5,980
-0.6% -$176K 0.57% 75
2015
Q4
$32.1M Buy
938,383
+682,061
+266% +$21.3M 0.75% 43
2015
Q3
$7.36M Buy
+256,322
New +$11M 0.18% 155

Other funds holding DPLO

GW&K Investment Management's DPLO Position: Q1 2019 in Review

GW&K Investment Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2019, closing a stake of 1,078,728 shares — an estimated $14.5M sold.

GW&K Investment Management first reported a position in DPLO in Q3 2015 and held it in 14 quarters. The position peaked at $32.1M in Q4 2015. 150 funds tracked by Wall St. Rank hold DPLO as of Q1 2019.

  • GW&K Investment Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2019 after selling out during the quarter.
  • GW&K Investment Management sold 1,078,728 DIPLOMAT PHARMACY, INC. shares in Q1 2019, an estimated $14.5M.
  • GW&K Investment Management first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2015 and held it in 14 quarters.
  • GW&K Investment Management's DIPLOMAT PHARMACY, INC. position peaked at $32.1M in Q4 2015.
  • 150 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2019.

Based on GW&K Investment Management's 13F filing for Q1 2019, filed 14 May 2019.